Epidemiology and Health

Brief Communication

Prophylactic efficacy of probiotics on travelers’ diarrhea: an adaptive meta-analysis of randomized controlled trials: Jong-Myon Bae; Epidemiol Health. 2018;40:e2018043. Published online August 29, 2018; DOI: https://doi.org/10.4178/epih.e2018043

17,477 View
460 Download
20 Web of Science
18 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
The 2017 guideline for the prevention of travelers’ diarrhea (TD) by the International Society of Travel Medicine suggested that ‘there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat TD.’ However, a meta-analysis published in 2007 reported significant efficacy of probiotics in the prevention of TD (summary relative risk [sRR], 0.85, 95% confidence interval [CI], 0.79 to 0.91). This study aimed to synthesize the efficacy of probiotics on TD by updating the meta-analysis of double-blind, placebo-controlled, randomized human trials.

METHODS

The search process was conducted by the adaptive meta-analysis method using the ‘cited by’ and ‘similar articles’ options provided by PubMed. The inclusion criteria were double-blind, placebo-controlled, randomized human trials with hypotheses of probiotics as intervention and TD as an outcome. The adaptive meta-analysis was conducted using Stata software using the csi, metan, metafunnel, and metabias options.

RESULTS

Eleven articles were selected for the meta-analysis. The sRR was 0.85 (95% CI, 0.79 to 0.91) and showed statistical significance. There was no heterogeneity (I-squared=28.4%) and no publication bias.

CONCLUSIONS

Probiotics showed statistically significant efficacy in the prevention of TD.

Summary

Korean summary
활생제가 여행자설사를 예방하는 효과가 있는가에 대한 기존 메타분석결과들과 지침간의 괴리가 확인되어서 갱신용 메타분석을 수행하였다. 총 11편의 무작위배정, 위약대조비교 임상시험결과에 대한 메타분석결과 통계적으로 유의한 효과가 있는 것으로 산출되었다 (summary relative risk =0.85; 95% confidence interval: 0.77-0.91).

Citations

Citations to this article as recorded by

The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Nicoleta-Maricica Maftei, Cosmin Raducu Raileanu, Alexia Anastasia Balta, Lenuta Ambrose, Monica Boev, Denisa Batîr Marin, Elena Lacramioara Lisa
Microorganisms.2024; 12(2): 234. CrossRef
Next generation probiotics: Engineering live biotherapeutics
Sanjeeva Kumar Murali, Thomas J. Mansell
Biotechnology Advances.2024; 72: 108336. CrossRef
Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers’ diarrhea: a systematic review and network meta-analysis
Hao Fan, I-Chun Liu, Lei Gao, Lanka Wu
Frontiers in Pharmacology.2024;[Epub] CrossRef
Haben Probiotikastämme einen nachweisbaren Stellenwert?
Jonas Früh
Flugmedizin · Tropenmedizin · Reisemedizin - FTR.2024; 31(03): 110. CrossRef
Controlling Intestinal Infections and Digestive Disorders Using Probiotics
Sanjeev Kumar, Md Faruque Ahmad, Priyakshi Nath, Rubina Roy, Rudrarup Bhattacharjee, Eman Shama, Indira Gahatraj, Manisha Sehrawat, Vaishali Dasriya, Harmeet Singh Dhillon, Monica Puniya, Mrinal Samtiya, Tejpal Dhewa, Rotimi E. Aluko, Gulab D. Khedkar, An
Journal of Medicinal Food.2023; 26(10): 705. CrossRef
Antibiotic treatment to reduce the duration and severity of travellers’ diarrhoea
Romeo Toriro, William Nevin, Rebecca Kuehn, Hannah Ryan, Nicholas Beeching, Tom Fletcher, Dan Burns
Cochrane Database of Systematic Reviews.2023;[Epub] CrossRef
Phenotypic Assessment of Probiotic and Bacteriocinogenic Efficacy of Indigenous LAB Strains from Human Breast Milk
Senbagam Duraisamy, Fazal Husain, Senthilkumar Balakrishnan, Aswathy Sathyan, Prabhu Subramani, Prahalathan Chidambaram, Selvaraj Arokiyaraj, Wahidah H. Al-Qahtani, Jothiramalingam Rajabathar, Anbarasu Kumarasamy
Current Issues in Molecular Biology.2022; 44(2): 731. CrossRef
Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature
Bantayehu Addis Tegegne, Bekalu Kebede
Heliyon.2022; 8(6): e09725. CrossRef
Probiotics and rifaximin for the prevention of travelers’ diarrhea: A systematic review and network meta-analysis
Hao Fan, Lei Gao, Zidan Yin, Sheng Ye, Hua Zhao, Qi Peng
Medicine.2022; 101(40): e30921. CrossRef
Gut Microbiota-targeted Interventions for Reducing the Incidence, Duration, and Severity of Respiratory Tract Infections in Healthy Non-elderly Adults
J Philip Karl
Military Medicine.2021; 186(3-4): e310. CrossRef
The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009–2020
A. Darb Emamie, M. Rajabpour, R. Ghanavati, P. Asadolahi, S. Farzi, B. Sobouti, A. Darbandi
Journal of Applied Microbiology.2021; 130(6): 1823. CrossRef
Pediatric Digestive Health and the Gut Microbiome: Existing Therapies and a Look to the Future
Samantha Saul, Jessika Fuessel, Joseph Runde
Pediatric Annals.2021;[Epub] CrossRef
A Brief Overview on Probiotics: The Health Friendly Microbes
Sanjukta Mishra, Swastik Acharya
Biomedical and Pharmacology Journal.2021; 14(4): 1869. CrossRef
Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
Maria Aponte, Nicoletta Murru, Mahtab Shoukat
Frontiers in Microbiology.2020;[Epub] CrossRef
Probiotics: Reiterating What They Are and What They Are Not
Gregor Reid, Azza A. Gadir, Raja Dhir
Frontiers in Microbiology.2019;[Epub] CrossRef
Probiotics and prebiotics in clinical tests: an update
Harald Brüssow
F1000Research.2019; 8: 1157. CrossRef
A successful history: probiotics and their potential as antimicrobials
Luigi Santacroce, Ioannis Alexandros Charitos, Lucrezia Bottalico
Expert Review of Anti-infective Therapy.2019; 17(8): 635. CrossRef
Emerging concepts in the diagnosis, treatment, and prevention of travelers’ diarrhea
Lorne Schweitzer, Bhagteshwar Singh, Priscilla Rupali, Michael Libman
Current Opinion in Infectious Diseases.2019; 32(5): 468. CrossRef

First
Prev
Page of 1
Next
Last

Search